Dialytic Management of Diabetic Uremic Patients

  • Eli A. Friedman
  • Anne Marie V. Miles


Diabetic nephropathy is the most prevalent cause of endstage renal disease (ESRD) in the United States. According to the 1994 United States Renal Data System (USRDS) report, diabetes accounted for 17,882 of 49,909 (35.8%) incident cases (Figure 1) and 48,274 of 186,261 (24.9%) prevalent cases of ESRD in the US in 1991 (1). The lower prevalence than incidence of diabetic ESRD patients in the US is a consequence of their higher mortality during uremia therapy. This point is illustrated in Figure 2 which plots relative survival for diabetic versus the entire population of hemodialysis and peritoneal dialysis patients


Diabetic Nephropathy Peritoneal Dialysis Hemodialysis Patient Continuous Ambulatory Peritoneal Dialysis Maintenance Hemodialysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    United States Renal Data System: USRDS 1994 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive Diseases, Bethesda, MD, September 1994Google Scholar
  2. 2.
    Avram MM: Use of special hemodialysis methods in diabetic uremia. Proc Confort Dialysis as a Practical Workshop, National Union Catalogue, NY, 1966, p 15Google Scholar
  3. 3.
    Chazan BI, Rees SB, Balodimus MS et al.: Dialysis in diabetics. A review of 44 patients. J Am Med Assoc 1969; 209: 2026–2030.Google Scholar
  4. 4.
    Comty CM, Leonard A, Shapiro FL: Management and prognosis of diabetic patients treated by chronic hemodialysis. (Abstract) Am Soc Nephrol 5: 15, 1971Google Scholar
  5. 5.
    Comty CM, Kjellsen D, Shapiro FL: A reassessment of the prognosis of diabetic patients treated by chronic hemodialysis. Trans Am Soc Artif Intern Organs 22: 404, 1976PubMedGoogle Scholar
  6. 6.
    Ghavamian M, Gutch CF, Kopp KF et al.: The sad truth about hemodialysis in diabetic nephropathy. J Am Med Assoc 222: 1386, 1972Google Scholar
  7. 7.
    Jacobs C, Broyer M, Brunner FP et al.: Combined report on regular dialysis and transplantation in Europe, XI. 1980. Presented at the 17th Congress of the European Dialysis and Transplantation Association, Paris, July 5–8th, 1981Google Scholar
  8. 8. Canadian Organ Replacement Register: New and registered patients in 1989. Toronto, 1989, p 35Google Scholar
  9. 9.
    Shapiro FL, Comty CM: Hemodialysis in diabetics — 1981 update, in Diabetic Renal Retinal Syndrome, edited by Friedman EA, L’Esperance FA, New York, Grune and Stratton, 1981, p 309Google Scholar
  10. 10.
    Ma KW, Master DS, Brown DC: Hemodialysis in diabetic patients with chronic renal failure. Ann Intern Med 53: 215, 1975Google Scholar
  11. 11.
    Kjellstrand CM, Whitley K, Comty CM et al.: Dialysis in patients with diabetes mellitus nephropathy. Diabetic Nephropathy 2: 15, 1983Google Scholar
  12. 12.
    Whitley KY, Shapiro FL: Hemodialysis for end-stage diabetic nephropathy. in Diabetic Renal Retinal Syndrome, edited by Friedman EA, L’Esperance FA, New York, Grune and Stratton, 1986, p 349Google Scholar
  13. 13.
    Zander E, Schultz B, Beckett R et al.: Clinical course in insulin-dependent diabetics undergoing hemodialysis. Exp Clin Endocrinol 85: 105, 1985PubMedCrossRefGoogle Scholar
  14. 14.
    Kjellstrand CM: A comparison of dialysis and transplantation in patients with end-stage renal failure of diabetes, in Diabetic Renal Retinal Syndrome, edited by Friedman EA, L’Esperance FA, New York, Grune and Stratton, 1986, p 333Google Scholar
  15. 15.
    Balodimus MC: Diabetic nephropathy. in: Joslin’s Diabetes, edited by Marbel A, White P, Bradley RF et al., Philadelphia: Lea and Febiger, 1971, p 526Google Scholar
  16. 16.
    Marks HH: Longevity and mortality of diabetics. Am J Public Health 55: 416, 1965Google Scholar
  17. 17.
    Humphrey LL, Ballard DJ, Frohnert PP et al.: Chronic renal failure in non-insulin dependent diabetes mellitus. Ann Intern Med 111: 788, 1989PubMedGoogle Scholar
  18. 18.
    Hasslacher CH, Ritz E, Wahl P et al.: Similar risks of nephropathy in patients with type I or type II diabetes mellitus. Nephrol Dial Transplant 4: 859, 1989PubMedGoogle Scholar
  19. 19.
    Nelson RG, Newman JM, Knowles WC et al.: Incidence of end-stage renal disease in type 2 (non-insulin dependent) diabetes mellitus in Pima Indians. Diabetologia 31: 730, 1988PubMedGoogle Scholar
  20. 20.
    Cowie CC, Port FK, Wolfe RA et al.: Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 321: 1074, 1989PubMedCrossRefGoogle Scholar
  21. 21.
    James E, Knowles WC, Bennett PH: Incidence and risk factors for non-insulin dependent diabetes. Diabetes in America. Washington DC, US Govt Printing Office, 1985, IV-I, NIH Publication No 85-1468.Google Scholar
  22. 22.
    Nostrand SG, Kirk RA, Rutsky EA et al.: Racial differences in the incidence of treatment for end stage renal disease. N Engl J Med 306: 1276, 1982CrossRefGoogle Scholar
  23. 23.
    Pugh JA, Stern MP, Haffner Fl et al.: Excess incidence of end stage renal disease in Mexican Americans. Am J Epidemiol 127: 135, 1988PubMedGoogle Scholar
  24. 24.
    Waring GO: The sequelae of diabetes in mid-Western American Indians. Diabetes 19: 403, 1970Google Scholar
  25. 25.
    Mogensen CE, Christensen CK, Vittinghus E: The stages of diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy. Diabetes 32: 64, 1983PubMedGoogle Scholar
  26. 26.
    Earle K, Viberti GC: Familial, hemodynamic and metabolic factors in the predisposition to diabetic kidney disease. Kidney Int 45: 434, 1994PubMedGoogle Scholar
  27. 27.
    Harris MI, Klein R, Welborn TA, Knuiman MW: Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 15: 815, 1992PubMedGoogle Scholar
  28. 28.
    Harris MI: Impaired glucose tolerance in the US population. Diabetes Care 12: 464, 1989PubMedGoogle Scholar
  29. 29.
    Nolph KD, Lundblad AS, Novak JW: Current concepts: continuous Ambulatory Peritoneal Dialysis. N Engl J Med 318: 1595, 1988PubMedGoogle Scholar
  30. 30.
    Kussman MJ, Goldstein HH, Gleason RE: The clinical course of diabetic nephropathy. J Am Med Assoc 236: 1861, 1976Google Scholar
  31. 31.
    Friedman EA (Ed): Death on Hemodialysis: Preventable or Inevitable?, Dordrecht, The Netherlands, Kluwer Academic Publishers, 1994Google Scholar
  32. 32.
    US Renal Data System: USRDS 1993 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, August 1993Google Scholar
  33. 33.
    Koch M, Thomas B, Tschope W, Ritz E: Survival and predictors of death in dialysed diabetic patients. Diabetologia 36: 1113, 1993PubMedGoogle Scholar
  34. 34.
    Legrain M, Rottemburg J, de Groc F et al.: Selecting the best uremia therapy, in Diabetic Renal Retinal Syndrome, edited by Friedman EA, L’Esperance FA, New York, Grune and Stratton, 1986, p 453Google Scholar
  35. 35.
    Berman DH, Friedman EA, Lundin AP: Aggressive ophthalmological management in diabetic ESRD: a study of 31 consecutively referred patients. Am J Nephrol 12: 344, 1992PubMedGoogle Scholar
  36. 36.
    Friedman EA: Physician bias in uremia therapy. Kidney Int Suppl A: S38, 1985Google Scholar
  37. 37.
    Ortega-Gayton M, Hong JH, Shirani K et al.: Angioaccess for maintenance hemodialysis in end stage diabetic nephropathy. Proc Clin Dial Transplant Forum 9: 99, 1979Google Scholar
  38. 38.
    Palder SB, Kirkman RL, Whittemore AD: Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg 202: 235, 1985PubMedGoogle Scholar
  39. 39.
    Kjellstrand CM, Simmons RL, Goetz FC et al.: Mortality and morbidity in diabetic patients accepted for renal transplantation. Proc Eur Dialysis Transplant Assoc 9: 345, 1972Google Scholar
  40. 40.
    Maison M, Kjellstrand CM: Long term followup of 369 diabetic patients undergoing dialysis. Arch Intern Med 148: 600, 1988Google Scholar
  41. 41.
    Weinrauch LA, Delia JA, Gleason RE, Hampton LA, Smith-Ossman S, DeSilva RA, Nesto RW: Usefulness of left ventricular size and function in predicting survival in chronic dialysis patients with diabetes mellitus. Am J Cardiol 70: 300, 1992PubMedGoogle Scholar
  42. 42.
    Ansari A, Kaupke CJ, Vaziri ND, Miller R, Barbari A: Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis. Int J Artif Organs 16: 31, 1993PubMedGoogle Scholar
  43. 43.
    Rubin JE, Friedman EA: Dialysis and transplantation of diabetics in the United States. Nephron 18: 309, 1977PubMedGoogle Scholar
  44. 44.
    Ritz E, Strumpf C, Katz F et al.: Hypertension and cardiovascular risk factors in hemodialyzed diabetic patients. Hypertension 7(Suppl II): 118, 1985Google Scholar
  45. 45.
    Herman WH, Teutsch SM: Kidney Disease associated with diabetes. Diabetes in America. Washington DC, US Govt Printing Office, 1985, XIV. 1–31 (NIH publication No 85-1468)Google Scholar
  46. 46.
    Khauli RB, Novick AC, Steinmuller DR et al.: Comparison of renal transplantation and dialysis in rehabilitation of diabetic end stage renal disease patients. Urology 27: 521, 1986PubMedGoogle Scholar
  47. 47.
    Watanabe Y, Yuzawa Y, Mizumoto D, Tamai H, Itoh Y, Kumon S, Yamazaki C: Long-term follow-up study of 268 diabetic patients undergoing haemodialysis, with special attention to visual acuity and heterogeneity. Nephrol Dial Transplant 8: 725, 1993PubMedGoogle Scholar
  48. 48.
    Shideman JR, Buselmeier TJ, Kjellstrand CM: Hemodialysis in diabetics. Arch Intern Med 136: 1126, 1976PubMedGoogle Scholar
  49. 49.
    Daugirdas JT: Dialysis hypotension: a hemodynamic analysis. Kidney Int 39: 223, 1991Google Scholar
  50. 50.
    Gotch FA, Keen ML, Yarian SR: An analysis of thermal regulation in hemodialysis with one and three compartment models. Trans Am Soc Artif Intern Organs 35: 622, 1989Google Scholar
  51. 51.
    Maggiore Q, Pizzarelli F, Zocalli C et al.: Effect of extracorporeal blood cooling on dialytic arterial hypotension. Proc Eur Dial Transplant Assoc 28: 597, 1981Google Scholar
  52. 52.
    Ifudu O, Dulin AL, Friedman EA: Interdialytic weight gain correlates with glycosylated hemoglobin in diabetic hemodialysis patients. Am J Kidney Dis 23: 686, 1994PubMedGoogle Scholar
  53. 53.
    Jones R, Poston R, Hinestrota A et al.: Weight gain between dialysis in diabetics. Possible significance of raised intracellular sodium content. Br Med J 1: 153, 1980.Google Scholar
  54. 54.
    Davis M, Comty C, Shapiro F: Dietary management of patients with diabetes treated by hemodialysis, J Am Diet Assoc 75: 265, 1979PubMedGoogle Scholar
  55. 55.
    Tzamaloukas AH, Murata GH, Eisenberg B, Murphy G, Avasthi PS: Hypoglycemia in diabetics on dialysis with poor glycemic control: hemodialysis versus continuous ambulatory peritoneal dialysis. Int J Artif Organs 15: 390, 1992PubMedGoogle Scholar
  56. 56.
    Hackelsberger N, Piwernetz K, Renner R, Gerhards W, Hepp KD: Postprandial blood glucose and its relation to diabetic gastroparesis — a comparison of two methods. Diabetes Res Clin Pract 20: 197, 1993PubMedGoogle Scholar
  57. 57.
    McLaughlin S: Nutritional considerations for other complications of diabetes. Diabetes Educ 18: 527, 1992PubMedGoogle Scholar
  58. 58.
    Klein R, Klein BEK: Vision disorders in diabetes. Diabetes in America. Washington DC, US Govt Printing Office, 1985, XIII. 1–36 (NIH publication No 85-1468)Google Scholar
  59. 59.
    Blagg CR: Visual and vascular problems in dialyzed diabetic patients. Kidney Int 6: S27, 1974Google Scholar
  60. 60.
    Goldstein DA, Massry SG: Diabetic nephropathy: clinical cause and effect on hemodialysis. Nephron 20: 286, 1978PubMedGoogle Scholar
  61. 61.
    Jacobs C, Rottemburg J, Frantz P et al.: Treatment of end-stage renal failure in the insulin-dependent diabetic patient. Adv Nephrol 8: 101, 1979Google Scholar
  62. 62.
    Berman DH, Friedman EA, Lundin AP: Aggressive ophthalmological management in diabetic ESRD: a study of 31 consecutively referred patients. Am J Nephrol 12: 344, 1992PubMedGoogle Scholar
  63. 63.
    Koch M, Tschope W, Ritz E: Does the care of diabetic patients with renal failure in the predialysis phase need improvement? Dtsch Med Wochensch 116: 1543, 1991Google Scholar
  64. 64.
    Tzamaloukas AH, Murata GH, Harford AM et al.: Hand gangrene in diabetic patients on chronic dialysis. Trans Am Soc Artif Intern Organs 37: 638, 1991Google Scholar
  65. 65.
    Butt KMH, Friedman EA, Kountz SL: Angioaccess. Curr Probl Surg 12:9, 1976Google Scholar
  66. 66.
    Mayers JD, Markell MS, Cohen LS et al.: Vascular access surgery for maintenance hemodialysis. Variables in hospital stay. ASAIO J 38: 113, 1992PubMedGoogle Scholar
  67. 67.
    Riggs JE, Moss AH, Labosky DA et al.: Upper extremity ischemic monomelic neuropathy: a complication of vascular access procedures in uremic diabetic patients. Neurology 1989; 39: 997–998.PubMedGoogle Scholar
  68. 68.
    Legrain M, Rottemburg J, Bentchikou A et al.: Dialysis treatment of insulin-dependent diabetic patients. Ten years experience. Clin Nephrol 21: 72, 1984PubMedGoogle Scholar
  69. 69.
    Clark DW, Nowak TV: Diabetic gastroparesis. What to do when gastric emptying is delayed. Postgrad Med 95: 195, 1994PubMedGoogle Scholar
  70. 70.
    Clark DW, Nowak TV: Diabetic gastroparesis. What to do when gastric emptying is delayed. Postgrad Med 95: 201, 1994Google Scholar
  71. 71.
    Battle WM, Cohen JD, Snape WJ Jr: Disorders of colonic motility in patients with diabetes mellitus. Yale J Biol Med 56: 277, 1983PubMedGoogle Scholar
  72. 72.
    Lux G: Disorders of gastrointestinal motility — diabetes mellitus. Leber Magen Darm 19: 84, 1989PubMedGoogle Scholar
  73. 73.
    Vincenti F, Arnaud SB, Recker R et al.: Parathyroid and bone response of the diabetic patient to uremia. Kidney Int 25: 677, 1984PubMedGoogle Scholar
  74. 74.
    Weiss RE, Reddi AH: Influence of experimental diabetes and insulin on matrix-induced cartilage and bone differentiation. Am J Physiol 238: E200, 1980PubMedGoogle Scholar
  75. 75.
    Andress DL, Kopp JB, Maloney NA et al.: Early deposition of aluminum in bone in diabetic patients on hemodialysis. N Engl J Med 316: 292, 1987PubMedCrossRefGoogle Scholar
  76. 76.
    Cheigh J, Raghavan J, Sullivan J et al.: Is insufficient dialysis a cause for high morbidity in diabetic patients. (Abstract) J Am Soc Nephrol 2: 317, 1991Google Scholar
  77. 77.
    Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001, 1993PubMedGoogle Scholar
  78. 78.
    Goldwasser P, Michel MA, Collier J, Mittman N, Fein PA, Gusik SA, Avram MM: Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival. Am J Kidney Dis 22: 215, 1993PubMedGoogle Scholar
  79. 79.
    Dremth JP, Engels LG: Diabetic gastroparesis. A critical reappraisal of new treatment strategies. Drugs 44: 537, 1992Google Scholar
  80. 80.
    Lindblad AS, Nolph KD, Novak JW, Friedman EA: A survey of the NIH CAPD Registry population with end-stage renal disease attributed to diabetic nephropathy. J Diabetic Complications 2: 227, 1988Google Scholar
  81. 81.
    Legrain M, Rottembourg J, Bentchikou A et al.: Dialysis treatment of insulin dependent diabetic patients. Ten years experience. Clin Nephrol 21: 72, 1984PubMedGoogle Scholar
  82. 82.
    Nolph KD: Is residual renal function preserved better with CAPD than with hemodialysis? AKF Nephrol Lett 7: 1, 1990Google Scholar
  83. 83.
    Flynn CT, Nanson JA: Intraperitoneal insulin with CAPD — An artificial pancreas. Trans Am Soc Artif Intern Organs 25: 114, 1979PubMedGoogle Scholar
  84. 84.
    Scarpioni LL, Ballocchi S, Castelli A et al.: Continuous ambulatory peritoneal dialysis in diabetic patients. Contrib Nephrol 84: 50, 1990Google Scholar
  85. 85.
    Fluckiger R, Harmon W, Meier W et al.: Hemoglobin carbamylation in uremia. N Engl J Med 304: 823, 1981PubMedCrossRefGoogle Scholar
  86. 86.
    Tzamaloukas AH, Oreopoulos DG: Subcutaneous versus intraperitoneal insulin in the management of diabetics on CAPD: a review. Adv Perit Dial 7: 81, 1991PubMedGoogle Scholar
  87. 87.
    Rubin J, Hsu H: Continuous ambulatory peritoneal dialysis: ten years at one facility. Am J Kidney Dis 17: 165, 1991PubMedGoogle Scholar
  88. 88. Anonymous editorial: Prevention of peritonitis in CAPD. Lancet 337: 22, 1991Google Scholar
  89. 89.
    Tzamaloukas AH, Oreopoulos DG: Subcutaneous versus intraperitoneal insulin in the management of diabetics on CAPD: a review. Adv Perit Dial 7: 81, 1991PubMedGoogle Scholar
  90. 90.
    Mitchell JC, Frohnert PP, Kurtz SB et al.: Chronic peritoneal dialysis in juvenile-onset diabetes mellitus. A comparison with hemodialysis. Mayo Clin Proc 53: 775, 1978PubMedGoogle Scholar
  91. 91.
    Levin ME: Peripheral vascular disease in the person with diabetes, in Diabetes Mellitus, edited by Rifkin, H, New York, Elsevier, 1990, p 768Google Scholar
  92. 92.
    Held PJ, Port FK, Blagg CR et al.: The United States Renal Data Systems’ Annual Data Report. Am J Kidney Dis 16(Suppl 2):34, 1990Google Scholar
  93. 93.
    Yuan ZY, Balaskas E, Gupta A et al.: Is CAPD or hemodialysis better for diabetic patients? CAPD is more advantageous. Semin Dial 5: 181, 1992Google Scholar
  94. 94.
    Nolph KD: Continuous ambulatory peritoneal dialysis as long term treatment for end stage renal disease. Am J Kidney Dis 17: 154, 1991PubMedGoogle Scholar
  95. 95.
    Khanna R, Oreopoulos DG: Continuous ambulatory peritoneal dialysis in diabetics with end stage renal disease. A combined experience of 2 North American centers, in Diabetic Renal Retinal Syndrome, edited by Friedman EA, L’Esperance FA, New York, Grune and Stratum, 1986, p 363Google Scholar
  96. 96.
    Rottemburg J: Peritoneal dialysis in diabetics, in Peritoneal Dialysis, edited by Nolph KD, Boston, Martinus Nijhoff, 1985, p 365Google Scholar
  97. 97.
    Rubin J, Oreopoulos DG, Blair RDG et al.: Chronic peritoneal dialysis in the management of diabetics with terminal renal failure. Nephron 19: 265, 1977PubMedGoogle Scholar
  98. 98.
    Gotch F: The application of urea kinetic modelling to CAPD. in Peritoneal Dialysis, edited by La Greca G, Ronco C, Feriani M et al., Milano, Wichtig Editore, 1991, p 47Google Scholar
  99. 99.
    Gokal R, Jakubowski C, Hunt L: Multicenter study of outcome of CAPD and hemodialysis patients. Nephrol Dial Transplant 1: 111, 1986Google Scholar
  100. 100.
    Young GA, Kopple JD, Lindholm B et al.: Nutritional assessment of chronic ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis 17: 462, 1991PubMedGoogle Scholar
  101. 101.
    Rotellar C, Black J. Winchester JF et al.: Ten years experience with continuous ambulatory peritoneal dialysis. AmJ Kidney Dis 17: 158, 1991Google Scholar
  102. 102.
    Miller DG, Levine S, Bistrian B et al.: Diagnosis of protein calorie malnutrition in diabetic patients on hemodialysis and peritoneal dialysis. Nephron 33: 127, 1983PubMedGoogle Scholar
  103. 103.
    Blumenkrantz MJ, Gahl GM, Kopple JD et al.: Protein losses during peritoneal dialysis. Kidney Int 19: 593, 1981PubMedGoogle Scholar
  104. 104.
    Krediet RT, Zuyderhoudt FMJ, Boeschoten EW et al.: Peritoneal permeability to protein in diabetic and non-diabetic continuous ambulatory dialysis patients. Nephron 42: 133, 1986PubMedGoogle Scholar
  105. 105.
    Oreopoulos DG, Yuan ZY: CAPD in diabetics. Presented at the American Society of Nephrology Annual Meeting, November, 1991, Baltimore, MDGoogle Scholar
  106. 106.
    Sutherland DER, Morrow CE, Fryd DS, Ferguson R, Simmons RL, Najarian JS: Improved patient and primary renal allograft survival in uremic diabetic recipients. Transplantation 34: 319, 1982PubMedCrossRefGoogle Scholar
  107. 107.
    Sollinger HW, Ploeg RJ, Eckhoff DE, Stegall MD, Isaacs R, Pirsch JD, D’Alessandro AM, Knechtle SJ, Kalayoglu M Beizer FO: Two hundred consecutive simultaneous pancreas-kidney transplants with bladder drainage. Surgery 114: 736, 1993PubMedGoogle Scholar
  108. 108.
    Robertson RP: Pancreas transplantation in humans with diabetes mellitus. Diabetes 40: 1085, 1991PubMedGoogle Scholar
  109. 109.
    Diagnostic and therapeutic technology assessment (DATTA). Pancreatic transplantations. JAMA 265: 510, 1991Google Scholar
  110. 110.
    Cecka JM, Terasaki PI: 1991. The UNOS Scientific Renal Transplant Registry — 1991. Clinical Transplants 1991, edited by Terasaki PI, UCLA Tissue Typing Lab, Los Angeles CA, 1992, p 1Google Scholar
  111. 111.
    Sutherland D, Gruessner A, Moudry-Munns K: International Pancreas Transplant Registry report. Transplant Proc 26: 407, 1994PubMedGoogle Scholar
  112. 112.
    Kennedy WR, Navarro X, Goetz FC et al.: Effects of Pancreatic Transplantation on Diabetic Neuropathy. N Engt J Med 322: 1031, 1990CrossRefGoogle Scholar
  113. 113.
    Ramsay RC, Goetz FC, Sutherland DE, Mauer SM, Robison LL, Cantril HL, Knobloch WH, Najarian JS: Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med 318:208, 1988PubMedCrossRefGoogle Scholar
  114. 114.
    Remuzzi G, Ruggenenti P, Mauer SM: Pancreas and kidney/pancreas transplants: experimental medicine or real improvement? Lancet 353: 27, 1994Google Scholar
  115. 115.
    Katz H, Homan M, Velosa J et al.: Effects of pancreas transplantation on postprandial glucose metabolism. N Engl J Med 325: 1278, 1991PubMedCrossRefGoogle Scholar
  116. 116.
    Taylor RJ, Bynon JS, Stratta RJ: Kidney/pancreas transplantation: a review of the current status. Urol Clin North Am 21: 343, 1994PubMedGoogle Scholar
  117. 117.
    Manske CL, Wang Y, Rector T et al.: Coronary revascularization in insulin-dependent diabetic patients with chronic renal failure. Lancet 340: 998, 1992PubMedGoogle Scholar
  118. 118.
    Kamofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer, in Evaluation of Chemotherapeutic Agents, edited by MacLeod CM, New York, Columbia University Press, 1949, p 191Google Scholar
  119. 119.
    Carlson DM, Johnson WJ, Kjellstrand CM: Functional status of patients with end-stage renal disease. Mayo Clin Proc 62: 338, 1987PubMedGoogle Scholar
  120. 120.
    Gutman RA, Stead WW, Robinson RR: Physical activity and employment status of patients on maintenance dialysis. N Engl J Med 304: 309, 1981PubMedCrossRefGoogle Scholar
  121. 121.
    Lowder GM, Perri NA, Friedman EA: Demographics, diabetes type, and degree of rehabilitation in diabetic patients on maintenance hemodialysis in Brooklyn. J Diabetic Complications 2: 218, 1988Google Scholar
  122. 122.
    Ifudu O, Paul H, Mayers JD, Cohen LS, Brezsynyak WF, Herman AI, Avram MM, Friedman EA: Pervasive failed rehabilitation in center-based maintenance hemodialysis patients. Am J Kidney Dis 23: 394, 1994PubMedGoogle Scholar
  123. 123.
    Ifudu O, Mayers J, Matthew J, Tan CC, Cambridge A, Friedman EA: Dismal rehabilitation in geriatric innercity hemodialysis patients. JAMA 271: 29, 1994PubMedGoogle Scholar
  124. 124.
    Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325: 836, 1991PubMedCrossRefGoogle Scholar
  125. 125.
    Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Cucala R: Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci USA 89: 12043, 1992PubMedGoogle Scholar
  126. 126.
    Brownlee M: Glycosylation of proteins and microangiopathy. Hosp Pract (Off Ed) 27(Suppl 1): 46, 1992Google Scholar
  127. 127.
    Ellis EN, Good BH: Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus. Metabolism 40: 1016, 1991PubMedGoogle Scholar
  128. 128.
    Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M: Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 88: 11555, 1991PubMedGoogle Scholar
  129. 129.
    Yagihashi S, Kamijo M, Baba M, Yagihashi M, Nagai K: Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 41: 47, 1992PubMedGoogle Scholar
  130. 130.
    Brownlee M: Pharmacological modulation of the advanced glycosylation reaction. Prog Clin Biol Res 304: 235, 1989PubMedGoogle Scholar
  131. 131.
    Nicholls K, Mandel TE: Advanced glycosylation end-products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine. Lab Invest 60: 486, 1989PubMedGoogle Scholar
  132. 132.
    Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR Jr, Williamson JR, McDaniel ML: Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 4: 552, 1992Google Scholar
  133. 133.
    Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML et al.: Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42: 221, 1993PubMedGoogle Scholar
  134. 134.
    Sensi M, Pricci F, Andreani D, DiMario U: Advanced nonenzymatic glycation endproducts (AGE): their relevance to aging and the pathogenesis of late diabetic complications. Diabetes Res 16: 1, 1991PubMedGoogle Scholar
  135. 135.
    Edelstein D, Brownlee M: Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41: 26, 1992PubMedGoogle Scholar
  136. 136.
    Eika B, Levin RM, Longhurst PA: Collagen and bladder function in streptozotocin-diabetic rats: effects of insulin and aminoguanidine. J Urol 148: 167, 1992PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Eli A. Friedman
    • 1
  • Anne Marie V. Miles
    • 2
  1. 1.SUNY Health Science CenterBrooklynUSA
  2. 2.SUNY-Health Science Center at BrooklynBrooklynUSA

Personalised recommendations